+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1aya | ||||||
---|---|---|---|---|---|---|---|
タイトル | CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO-TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE | ||||||
![]() |
| ||||||
![]() | HYDROLASE(SH2 DOMAIN) | ||||||
機能・相同性 | ![]() metanephric glomerular mesangium development / response to ceramide / Signaling by PDGF / PI-3K cascade:FGFR3 / PI-3K cascade:FGFR4 / Co-inhibition by BTLA / platelet-derived growth factor receptor activity / cell migration involved in coronary angiogenesis / metanephric glomerular mesangial cell proliferation involved in metanephros development / PI-3K cascade:FGFR1 ...metanephric glomerular mesangium development / response to ceramide / Signaling by PDGF / PI-3K cascade:FGFR3 / PI-3K cascade:FGFR4 / Co-inhibition by BTLA / platelet-derived growth factor receptor activity / cell migration involved in coronary angiogenesis / metanephric glomerular mesangial cell proliferation involved in metanephros development / PI-3K cascade:FGFR1 / PI-3K cascade:FGFR2 / FRS-mediated FGFR3 signaling / FRS-mediated FGFR4 signaling / MET activates PTPN11 / Regulation of IFNA/IFNB signaling / FRS-mediated FGFR1 signaling / FRS-mediated FGFR2 signaling / Tie2 Signaling / positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway / PECAM1 interactions / Interleukin-20 family signaling / smooth muscle cell chemotaxis / Signaling by CSF3 (G-CSF) / cardiac vascular smooth muscle cell differentiation / GAB1 signalosome / PI3K Cascade / MAPK3 (ERK1) activation / MAPK1 (ERK2) activation / Co-inhibition by CTLA4 / Regulation of RUNX1 Expression and Activity / metanephric glomerular capillary formation / Interleukin-6 signaling / Negative regulation of FGFR3 signaling / Negative regulation of FGFR4 signaling / Downstream signal transduction / Negative regulation of FGFR1 signaling / Negative regulation of FGFR2 signaling / GPVI-mediated activation cascade / Spry regulation of FGF signaling / Co-inhibition by PD-1 / Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) / Signaling by SCF-KIT / cell migration involved in vasculogenesis / aorta morphogenesis / positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway / positive regulation of signal transduction / platelet-derived growth factor binding / negative regulation of hormone secretion / RAF/MAP kinase cascade / negative regulation of cortisol secretion / intestinal epithelial cell migration / microvillus organization / negative regulation of growth hormone secretion / PIP3 activates AKT signaling / retina vasculature development in camera-type eye / genitalia development / Platelet sensitization by LDL / ruffle assembly / atrioventricular canal development / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / negative regulation of cell adhesion mediated by integrin / Interleukin-3, Interleukin-5 and GM-CSF signaling / smooth muscle tissue development / RET signaling / cardiac myofibril assembly / cerebellar cortex formation / tissue homeostasis / negative regulation of neutrophil activation / positive regulation of hormone secretion / positive regulation of chemotaxis / regulation of protein export from nucleus / positive regulation of ossification / positive regulation of lipopolysaccharide-mediated signaling pathway / hormone metabolic process / negative regulation of chondrocyte differentiation / face morphogenesis / skeletal system morphogenesis / platelet formation / organ growth / triglyceride metabolic process / megakaryocyte development / adrenal gland development / negative regulation of type I interferon production / positive regulation of DNA biosynthetic process / peptide hormone receptor binding / positive regulation of smooth muscle cell migration / blood vessel development / positive regulation of calcium ion import / regulation of cell adhesion mediated by integrin / inner ear development / neurotrophin TRK receptor signaling pathway / Bergmann glial cell differentiation / peptidyl-tyrosine dephosphorylation / regulation of MAPK cascade / platelet-derived growth factor receptor signaling pathway / phosphoprotein phosphatase activity / ephrin receptor signaling pathway / fibroblast growth factor receptor signaling pathway / embryonic organ development / regulation of protein-containing complex assembly 類似検索 - 分子機能 | ||||||
生物種 | ![]() ![]() | ||||||
手法 | ![]() | ||||||
![]() | Lee, C.-H. / Kuriyan, J. | ||||||
![]() | ![]() タイトル: Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. 著者: Lee, C.H. / Kominos, D. / Jacques, S. / Margolis, B. / Schlessinger, J. / Shoelson, S.E. / Kuriyan, J. #1: ![]() タイトル: Binding of a High Affinity Phosphotyrosyl Peptide to the Src Sh2 Domain: Crystal Structures of the Complexed and Peptide-Free Forms 著者: Waksman, G. / Shoelson, S.E. / Pant, N. / Cowburn, D. / Kuriyan, J. #2: ![]() タイトル: Structures of Sh2 and SH3 Domains 著者: Kuriyan, J. / Cowburn, D. #3: ![]() タイトル: Crystal Structure of the Phosphotyrosine Recognition Domain Sh2 of V-Src Complexed with Tyrosine-Phosphorylated Peptides 著者: Waksman, G. / Kominos, D. / Robertson, S.R. / Pant, N. / Baltimore, D. / Birge, R.B. / Cowburn, D. / Hanafusa, H. / Mayer, B.J. / Overduin, M. / Resh, M.D. / Rios, C.B. / Silverman, L. / Kuriyan, J. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 58.5 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 42.8 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 435.2 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 441.7 KB | 表示 | |
XML形式データ | ![]() | 13.1 KB | 表示 | |
CIF形式データ | ![]() | 17.5 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||
2 | ![]()
| ||||||||
単位格子 |
|
-
要素
#1: タンパク質 | 分子量: 11528.979 Da / 分子数: 2 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() #2: タンパク質・ペプチド | 分子量: 1300.307 Da / 分子数: 2 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() #3: 水 | ChemComp-HOH / | Has protein modification | Y | |
---|
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 1.93 Å3/Da / 溶媒含有率: 36.35 % | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | *PLUS 温度: 4 ℃ / pH: 6 / 手法: 蒸気拡散法, ハンギングドロップ法 | ||||||||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
放射 | 散乱光タイプ: x-ray |
---|---|
放射波長 | 相対比: 1 |
反射 | *PLUS 最高解像度: 2.05 Å / 最低解像度: 30 Å / Num. all: 26661 / Num. obs: 11145 / % possible obs: 90.2 % / Rmerge(I) obs: 0.084 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 解像度: 2.05→6 Å / σ(F): 2 /
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.05→6 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: ![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS Rfactor obs: 0.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS タイプ: x_angle_d / Dev ideal: 3 |